JP Morgan: Advisory on $170m Forbion Led Series B Investment Round in Beacon Therapeutics

JP Morgan played a pivotal role as the sole placement agent in Beacon Therapeutics’ recent achievement of securing $170 million during its Series B funding round. Led by Forbion, a renowned life sciences venture capital firm, the investment will expedite the development of Beacon’s innovative ophthalmic gene therapies. These include their leading asset,

Barclays Exclusive: Behind the Sale of German Consumer Finance Unit to Bawag

Barclays has successfully divested its German consumer finance division to Bawag Group AG, marking a significant step in its strategy to streamline global operations. This sale, part of a broader effort to refine the bank’s structure, involved the Hamburg-based unit previously known as Barclaycard Germany, which was sold for a slight premium over its net […]